J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 75 (1994), 2367-2377; DOI 10.1099/0022-1317-75-9-2367
© 1994 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, S. M.
Right arrow Articles by Clements, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, S. M.
Right arrow Articles by Clements, J. B.
Agricola
Right arrow Articles by Brown, S. M.
Right arrow Articles by Clements, J. B.

Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2

S. Moira Brown, June Harland, Alasdair R. MacLean, Jürgen Podlech{dagger} and J. Barklie Clements

MRC Virology Unit, Institute of Virology, Church Street, Glasgow G11 5JR, U.K.

The herpes simplex virus (HSV) gene RL1 encodes the protein ICP34.5, which is a specific neurovirulence factor. Null mutants in RL1 fail to replicate in the central nervous system of mice and are therefore totally non-neurovirulent. Additionally, they fail to replicate in neurons of the peripheral nervous system, although they are capable of establishing and reactivating from a latent infection. As the precise function of ICP34.5 in HSV-neuronal interactions is unknown, we have studied the role of ICP34.5 in vitro by examining in detail the phenotypes of RL1-negative viruses in two defined tissue culture systems. The first was mouse embryo fibroblast 3T6 cells, in which RL1-negative mutants are impaired and the in vivo phenotype is mimicked. This impairment is amplified when the cells are in the stationary state. The second was mouse embryo testicular carcinoma F9 cells which, in the undifferentiated state, provide a reversal of phenotype; wild-type virus fails to grow but RL1-negative virus replicates efficiently. Differentiation results in the ability to support wild-type virus growth. The stage at which the replication cycle is blocked plus the role of cellular factors is addressed in both tissue culture systems. Evidence is provided that cell type and cell state are crucial to ICP34.5-cellular interaction and hence, based on these parameters, ICP34.5 can be defined as a host-range determinant. Identification of cellular proteins that specifically interact with or are homologues of ICP34.5 may lead to the identification of neuron-specific proteins that have a similar role.

{dagger} Present address: Institut für Virologie, Universitätsklinik, Mainz, Germany.

Received 10 February 1994; accepted 6 April 1994.


This article has been cited by other articles:


Home page
J. Virol.Home page
D. E. Alexander, S. L. Ward, N. Mizushima, B. Levine, and D. A. Leib
Analysis of the Role of Autophagy in Replication of Herpes Simplex Virus in Cell Culture
J. Virol., November 15, 2007; 81(22): 12128 - 12134.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Pasieka, T. Baas, V. S. Carter, S. C. Proll, M. G. Katze, and D. A. Leib
Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.
J. Virol., August 1, 2006; 80(15): 7600 - 7612.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
X. Jing and B. He
Characterization of the triplet repeats in the central domain of the {gamma}134{middle dot}5 protein of herpes simplex virus 1
J. Gen. Virol., September 1, 2005; 86(9): 2411 - 2419.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Jing, M. Cerveny, K. Yang, and B. He
Replication of Herpes Simplex Virus 1 Depends on the {gamma}134.5 Functions That Facilitate Virus Response to Interferon and Egress in the Different Stages of Productive Infection
J. Virol., July 15, 2004; 78(14): 7653 - 7666.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Cheng, K. Yang, and B. He
Dephosphorylation of eIF-2{alpha} Mediated by the {gamma}134.5 Protein of Herpes Simplex Virus Type 1 Is Required for Viral Response to Interferon but Is Not Sufficient for Efficient Viral Replication
J. Virol., September 15, 2003; 77(18): 10154 - 10161.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P G E Kennedy
Neurovirological methods and their applications
J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1016 - 1022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mao and K. S. Rosenthal
An N-terminal Arginine-rich Cluster and a Proline-Alanine-Threonine Repeat Region Determine the Cellular Localization of the Herpes Simplex Virus Type 1 ICP34.5 Protein and Its Ligand, Protein Phosphatase 1
J. Biol. Chem., March 22, 2002; 277(13): 11423 - 11431.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Jacobs, J. G. Tjuvajev, M. Dubrovin, T. Akhurst, J. Balatoni, B. Beattie, R. Joshi, R. Finn, S. M. Larson, U. Herrlinger, et al.
Positron Emission Tomography-based Imaging of Transgene Expression Mediated by Replication-conditional, Oncolytic Herpes Simplex Virus Type 1 Mutant Vectors in Vivo
Cancer Res., April 1, 2001; 61(7): 2983 - 2995.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
G. Coukos, A. Makrigiannakis, E. H. Kang, S. C. Rubin, S. M. Albelda, and K. L. Molnar-Kimber
Oncolytic Herpes Simplex Virus-1 Lacking ICP34.5 Induces p53-independent Death and Is Efficacious against Chemotherapy-resistant Ovarian Cancer
Clin. Cancer Res., August 1, 2000; 6(8): 3342 - 3353.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
G. Coukos, A. Makrigiannakis, E. H. Kang, D. Caparelli, I. Benjamin, L. R. Kaiser, S. C. Rubin, S. M. Albelda, and K. L. Molnar-Kimber
Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer
Clin. Cancer Res., June 1, 1999; 5(6): 1523 - 1537.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. Goatley, M. Marron, S. Jacobs, J. Hammond, J. Miskin, C. Abrams, G. Smith, and L. Dixon
Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5
J. Gen. Virol., March 1, 1999; 80(3): 525 - 535.
[Abstract]


Home page
J. Virol.Home page
L. Y. Lee and P. A. Schaffer
A Virus with a Mutation in the ICP4-Binding Site in the L/ST Promoter of Herpes Simplex Virus Type 1, but Not a Virus with a Mutation in Open Reading Frame P, Exhibits Cell-Type-Specific Expression of gamma 134.5 Transcripts and Latency-Associated Transcripts
J. Virol., May 1, 1998; 72(5): 4250 - 4264.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S Kesari, T. Lasner, K. Balsara, B. Randazzo, V. Lee, J. Trojanowski, and N. Fraser
A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system
J. Gen. Virol., March 1, 1998; 79(3): 525 - 536.
[Abstract]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Todo, R. L. Martuza, S. D. Rabkin, and P. A. Johnson
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
PNAS, May 22, 2001; 98(11): 6396 - 6401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1994 by the Society for General Microbiology.